Stanton Marshall S.

SVP, Clinical & MD Affair

Stanton Marshall S. has filed 7 SEC Form 4 filings (18 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Mar 4, 2026.

On the most recent filing, Stanton Marshall S. is listed as SVP, Clinical & MD Affair at ARTIVION, INC. Inside the rolling window, Stanton Marshall S. reported no open-market purchases and 8 open-market sales totaling $3.4M in AORT. The largest disclosed transaction in the window is a sale of 47,376 AORT shares on Nov 21, 2025, worth $2.1M.

Companies traded

Other insiders at AORT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$3.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
AORTSale$81KMar 4SEC ↗
AORTSale$58KMar 3SEC ↗
AORTSale$91KFeb 25SEC ↗
AORTSale$45KFeb 25SEC ↗
AORTSale$2.1MNov 24SEC ↗
AORTSale$675KNov 24SEC ↗
AORTSale$229KNov 14SEC ↗
AORTSale$114KNov 12SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Stanton Marshall S. made?

Stanton Marshall S. has filed 7 SEC Form 4 filings (18 transaction rows) across 1 company since 2025.

Which companies does Stanton Marshall S. trade?

Stanton Marshall S. has filed SEC Form 4 disclosures for 1 company, including AORT.

When was Stanton Marshall S.'s most recent SEC Form 4 filing?

Stanton Marshall S.'s most recent SEC Form 4 filing on Tracefour is dated Mar 4, 2026.

What is Stanton Marshall S.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Stanton Marshall S. is listed as SVP, Clinical & MD Affair.

What is Stanton Marshall S.'s total buy and sell value in the current window?

Inside the rolling retention window, Stanton Marshall S. bought $0 and sold $3.4M based on SEC Form 4 filings.

What was Stanton Marshall S.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 47,376 AORT shares on 2025-11-21, worth $2.1M, per SEC Form 4 filings.